BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 17582925)

  • 1. Pregabalin: new indication. Generalised anxiety: better to use benzodiazepine.
    Prescrire Int; 2007 Jun; 16(89):104. PubMed ID: 17582925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepines and anticonvulsants for social phobia (social anxiety disorder).
    Jefferson JW
    J Clin Psychiatry; 2001; 62 Suppl 1():50-3. PubMed ID: 11206035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregabalin treatment of anxiety in patients with substance use disorders.
    Raza S; Siddiqui UA; Megna JL; Schwartz TL; Batki SL
    Ann Pharmacother; 2010 May; 44(5):937-8. PubMed ID: 20388860
    [No Abstract]   [Full Text] [Related]  

  • 4. Pregabalin for the treatment of generalized anxiety disorder.
    Wensel TM; Powe KW; Cates ME
    Ann Pharmacother; 2012 Mar; 46(3):424-9. PubMed ID: 22395254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin-induced suicidal ideations.
    Mutschler J; Grosshans M; Herwig U; Heekeren K; Kawohl W; Brühl A
    Pharmacopsychiatry; 2011 May; 44(3):119. PubMed ID: 21318939
    [No Abstract]   [Full Text] [Related]  

  • 6. Pregabalin for peripheral neuropathic pain.
    Hadj Tahar A
    Issues Emerg Health Technol; 2005 Mar; (67):1-4. PubMed ID: 15806748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin in benzodiazepine withdrawal.
    Biermann T; Bleich S; Kornhuber J; Hillemacher T
    Pharmacopsychiatry; 2007 Nov; 40(6):292-3. PubMed ID: 18030656
    [No Abstract]   [Full Text] [Related]  

  • 8. Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
    Pande AC; Crockatt JG; Feltner DE; Janney CA; Smith WT; Weisler R; Londborg PD; Bielski RJ; Zimbroff DL; Davidson JR; Liu-Dumaw M
    Am J Psychiatry; 2003 Mar; 160(3):533-40. PubMed ID: 12611835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregabalin in the discontinuation of long-term benzodiazepines' use.
    Oulis P; Konstantakopoulos G; Kouzoupis AV; Masdrakis VG; Karakatsanis NA; Karapoulios E; Kontoangelos KA; Papadimitriou GN
    Hum Psychopharmacol; 2008 Jun; 23(4):337-40. PubMed ID: 18348245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response relationship of pregabalin in patients with generalized anxiety disorder. A pooled analysis of four placebo-controlled trials.
    Bech P
    Pharmacopsychiatry; 2007 Jul; 40(4):163-8. PubMed ID: 17694480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregabalin for the discontinuation of long-term benzodiazepines use: an assessment of its effectiveness in daily clinical practice.
    Bobes J; Rubio G; Terán A; Cervera G; López-Gómez V; Vilardaga I; Pérez M
    Eur Psychiatry; 2012 May; 27(4):301-7. PubMed ID: 21334859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregabalin for the treatment of social anxiety disorder.
    Kawalec P; Cierniak A; Pilc A; Nowak G
    Expert Opin Investig Drugs; 2015 Apr; 24(4):585-94. PubMed ID: 25361817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregabalin: From molecule to medicine.
    Kavoussi R
    Eur Neuropsychopharmacol; 2006 Jul; 16 Suppl 2():S128-33. PubMed ID: 16765030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Pregabalin (Lyrica(®) ) help patients reduce their use of benzodiazepines? A comparison with gabapentin using the Norwegian Prescription Database.
    Bramness JG; Sandvik P; Engeland A; Skurtveit S
    Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):883-6. PubMed ID: 22545971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregabalin for the treatment of generalised anxiety disorder.
    Montgomery SA
    Expert Opin Pharmacother; 2006 Oct; 7(15):2139-54. PubMed ID: 17020438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic blocking drugs in anxiety and stress.
    Noyes R
    Psychiatr Clin North Am; 1985 Mar; 8(1):119-32. PubMed ID: 2859576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pregabalin on subjective sleep disturbance symptoms during withdrawal from long-term benzodiazepine use.
    Rubio G; Bobes J; Cervera G; Terán A; Pérez M; López-Gómez V; Rejas J
    Eur Addict Res; 2011; 17(5):262-70. PubMed ID: 21701173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new benzodiazepine screened in a parallel double-blind test].
    Lens F
    Acta Psychiatr Belg; 1974 May; 74(3):327-37. PubMed ID: 4156150
    [No Abstract]   [Full Text] [Related]  

  • 19. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.
    Bandelow B; Wedekind D; Leon T
    Expert Rev Neurother; 2007 Jul; 7(7):769-81. PubMed ID: 17610384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability and use in co-administration of pregabalin in affective patients: a 6-month prospective naturalistic study.
    Dobrea C; Buoli M; Arici C; Camuri G; Dell'Osso B; Altamura AC
    Expert Opin Drug Saf; 2012 Nov; 11(6):893-9. PubMed ID: 22946673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.